These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A rapid response to pembrolizumab in a patient with metastatic melanoma.
    Author: Bayo Calero J, Aviñó Tarazona V.
    Journal: Immunotherapy; 2017 Mar; 9(3):225-228. PubMed ID: 28231724.
    Abstract:
    Prognosis for patients with metastatic melanoma stays poor. Recent advances in the field of immuno-oncology increased treatment options for these patients and gave chances for obtaining partial and even complete response, prolonging survival in a subset of patients. Here, we describe a case of a 55-year-old man with multiple melanoma metastases into lungs who showed an extraordinary response to pembrolizumab used as a first-line treatment. The therapy was well tolerated, with no adverse reactions reported.
    [Abstract] [Full Text] [Related] [New Search]